awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34388065-A822EFBF-DADC-477B-BA59-51BB9B2A87D7
Q34388065-A822EFBF-DADC-477B-BA59-51BB9B2A87D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34388065-A822EFBF-DADC-477B-BA59-51BB9B2A87D7
Optimal management of hereditary hemorrhagic telangiectasia.
P2860
Q34388065-A822EFBF-DADC-477B-BA59-51BB9B2A87D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34388065-A822EFBF-DADC-477B-BA59-51BB9B2A87D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f52122ac9d3548a33c477f11c9c3dd072319b3b
P2860
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.